4/ In a field built on inference, can a transdermal signal bring us close to real GFR than the biochemical surrogates we’ve trusted for decades?
Dorshow et al. Accuracy of Point-of-Care Transdermal GFR Methodology
🔗 www.kireports.org/article/S246...
🖼️by @elbaonelida.bsky.social
#NephSky
1/20 Hello everyone, welcome to www.kireportscommunity.org #Nephsky #Medsky Welcome to a #skytorial brought to you by @KIReports
Goodnight Blue Sky
Pastel sketch of ladies assembling to attend a May Ball
Shawls, pastel (one of my old May Week theme drawings)
#Cambridge #mayball #pastel
Pastel still life with some ranunculus flowers, alstroemeria and an iris in a vase with some bits of pot pourri
Pastel still life, including a nice vase bought in a shop attached to an auction house, some ranunculus flowers, alstroemeria and an iris. The dried items on the right came from a bag of pot pourri. This was probably sold at a Cambridge Drawing Society exhibition.
#pastel #flowers
Watercolour showing an evening scene in Trinity Lane, Cambridge
Under the lamp, another Cambridge May Week doodle, watercolour and Indian ink.
#Cambridge #watercolour #mayweek
To say it took a while is an understatement, because #NephJC has been around for 11 years (and still counting)...
🥁 We opened an Instagram account, so if you're around, can follow and interact 👣💞
#NephSky #Medsky
📣 WCN’26 Social Media Team Kickoff Meeting
We’re delighted to welcome our new team members 🙌🏼
Meet the people behind the content:
🔗 theisn.org/wcn/media/so...
#ISNWCN
🔬 Stay on top of the evidence
At #ISNWCN, the HIT & LBCT sessions spotlight the clinical trials that matter most for patient care, from late-breaking results to ongoing studies.
“As a community, this helps us stay on top of the evidence base,” says Adeera Levin. Read more: lite.spr.ly/6003OtWX
Meet the #ISNWCN Social Media Team! 🎉 A group of health pros bringing you live updates from WCN'26 in Yokohama, 🇯🇵, with scientific session coverage, quizzes, interviews, visual abstracts, workshops & more! Get ready for engaging content! lite.spr.ly/6008OsHw
#Dapagliflozin in CKD Patients with #Fabry Disease
#VisualAbstract by Elba Medina
www.kireports.org/article/S2468-0249(25)00...
It's 2026!🎉
We will be counting down the Top Ten Nephrology Stories of 2025 on 1/6/26 at 9 pm EST.
Join us on TWITTER (it will always be Twitter to us).
Come on by #NephJC faithful for a lively discussion! You picked & we're count'em down.
www.nephjc.com/news/2025/1/3/top-stories-in-nephrology-2025
Did we (meaning "you" of course, because you voted) get them right? Is there something missing or is the order wrong? #NephJC #TopTenStories2025
Come discuss with an international cadre of nephrologists & other interested parties on 1/6/26 at 9 pm EST on #Twitter
✨It's that time of the year again, to nominate the most deserving people in our community for #NephJCKidneys award
👇Here's a reminder of previous winners #Nephsky
📌You can nominate worthy individuals/ initiatives by using the hashtag or by using the form
www.nephjc.com/news/2026/1/...
The future of nephrology
22/🎥Functional imaging studies have enhanced our understanding of physiology & pathology. 📸
However, most techniques are limited by variability in platforms, protocols, and image analysis. Standardization is crucial to unlock their full potential!🤳
“Nuestras cicatrices nos hacen saber que nuestro pasado fue real”
Jane Austen
10/ Evaluating tubular function through dynamic physiological stress tests is essential for a comprehensive understanding of kidney function. e.g the furosemide stress test assesses renal tubular integrity.
https://www.kireportscommunity.org/post/towards-new-ways-of-assessing-kidney-function-where-to-look-to-improve
5/ Read the executive summary and watch the meeting video for more information. 🔥🔥Start with the majors' key research questions🔥🔥
Congratulations to Leo Riella and team reporting physiology aspects from the first porcine kidney transplanted to a human. Happy to have contributed findings on pig renin and the renin-angiotensin system. @natcomms.nature.com @nu-nephrology.bsky.social @nufeinbergmed.bsky.social
rdcu.be/eIyQt
Thanks to @asnpublications.bsky.social for highlighting our feature on a new syndrome of renal tubular alkalosis! www.kidneynews.org/view/journal... @nu-nephrology.bsky.social @nufeinbergmed.bsky.social
Do we continue to measure kidney function with tools from the last century?
The workshop for Kidney Function Assessment of @NIDDKgov proposes a revolution: Go beyond Creatinine & eGFR!
💥Check out this blog & Skytorial !🧵👇
@kireports.bsky.social
👇👇👇👇👇👇
www.kireportscommunity.org/post/towards...
1/Hey #NephTwitter! Welcome to a 🆕 #Skytorial brought to you by @kireports.bsky.social @isnkidneycare.bsky.social Our author is @elbaonelida.bsky.social nephrologist at Hospital General de Mexico 🇲🇽 @hgm_nefrologia. Please also check out www.kireportscommunity.org educational #blogposts. FOLLOW US!
The LIBERATE-D VA by
@sejalplakhani.bsky.social
Should we break the pattern of thrice weekly dialysis in AKI-D? #NephJC #NephSky
www.nephjc.com/news/liberateva
Join us for the last #NephJC of 2025, 12/16/25 at 9pm EST!🥳
How soon should we withhold dialysis in AKI?
We're discussing the LIBERATE-D trial #NephSky
This one might just change your mind 🧠🧠
Blog by @msocomd.bsky.social and @sejalplakhani.bsky.social
www.nephjc.com/news/liberated-aki
Gracias! @dramiliflores.bsky.social #NephSky
LIBERATE-D: El Resumen Visual — #NephJC
www.nephjc.com/news/2025/12/14/liberate-d-el-resumen-visual
🆕 #NephJCshort by @brianrifkin.bsky.social
RETREAT-FRAIL- pragmatic RCT: is less BP medication worse in octogenarians?
www.nephjc.com/news/hyperte...
Kidney Tertiary #LymphoidTissues and Poor #Immunosuppressive Response in #IgANephropathy #IgAN
#VisualAbstract by Elba Medina
www.kireports.org/article/S2468-0249(25)00...
#NephJCshort on BICAR-ICU2 #Medsky #Nephsky
✍️ By @nephroseeker.medsky.social
🎭 Bicarbonate makes the picture look cleaner: better pH, more time. But beneath the smoother numbers, the patient hasn't changed. It's the same story, just told in softer colors
www.nephjc.com/news/2025/10...
T3f: #NephJC
Whether dual inhibition APRIL/BAFF offers a longer-term advantage over APRIL-selective therapy remains a key question that only eGFR slope data will answer. APRIL-selective therapy also prevents its action at other receptors (BCMA).
Do you think either has the advantage?
